LEVONORGESTREL INTRAUTERINE SYSTEM AND CERVICAL CANCER. CLINICAL DIFFICULTIES
DOI:
https://doi.org/10.11603/24116-4944.2019.2.10931Keywords:
intrauterine systems releasing levonorgestrel, contraception, irregular bleeding, cervical cancerAbstract
Introduction. In recent years, intrauterine systems releasing levonorgestrel became popular. They are a reliable and safe means of contraception. However, the hormonal effects of such systems sometimes mask the clinical manifestations of intercurrent diseases, including those manifested by irregular uterine bleeding.
Case Description: The emergence of diagnostic difficulties in the occurrence of cervical cancer in two women who used intrauterine systems releasing levonorgestrel.
Conclusion. Proper evaluation of irregular vaginal bleeding, including cervical cytology, is a prerequisite for all women who are carriers of intrauterine systems releasing levonorgestrel.
References
Nelson, A.L. (2017). Levonorgestrel-releasing intrauterine system (LNG-IUS 12) for prevention of pregnancy for up to five years. Expert Rev. Clin. Pharmacol.,, 10 (8), 833-842. DOI: https://doi.org/10.1080/17512433.2017.1341308
Mejia, M., McNicholas, C., Madden, T., & Peipert, J.F. (2016). Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use. Contraception, 94 (5), 556-560. DOI: https://doi.org/10.1016/j.contraception.2016.06.013
Mansour, D. (2012). The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception. Contraception, 85 (3), 224-234. DOI: https://doi.org/10.1016/j.contraception.2011.08.003
Papaikonomou, K., Kopp Kallner, H., Söderdahl, F., & Gemzell-Danielsson, K. (2018). Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial. Hum. Reprod., 33 (11), 2002-2009. DOI: https://doi.org/10.1093/humrep/dey296
Carty, J.R., Batig, T.S., Heitmann, R.J., Hammons, C.B., & Batig, A.L. (2019). Women's health and contraceptive practices of army physician assistants. Mil. Med., 184 (3-4), e169-e174. DOI: https://doi.org/10.1093/milmed/usy191
Averbach, S., Silverberg, M.J., Leyden, W., Smith-McCune, K., Raine-Bennett, T., & Sawaya, G.F. (2018). Recent intrauterine device use and the risk of precancerous cervical lesions and cervical cancer. Contraception, pii: S0010-7824(18)30144-6.
Wiegratz, I., & Thaler, C.J. (2011). Hormonal contraception – what kind, when, and for whom? Dtsch. Arztebl. Int., 108 (28-29), 495-505.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
